Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Validation of a hemoglobin A1c model in patients with type 1 and type 2 diabetes and its use to go beyond the averaged relationship of hemoglobin A1c and mean glucose level.

Ladyzynski P, Foltynski P, Bak MI, Sabalinska S, Krzymien J, Kawiak J.

J Transl Med. 2014 Dec 10;12:328. doi: 10.1186/s12967-014-0328-5.

2.

Characterizing accuracy and precision of glucose sensors and meters.

Rodbard D.

J Diabetes Sci Technol. 2014 Sep;8(5):980-5. doi: 10.1177/1932296814541810. Epub 2014 Jul 18.

3.

Diabetes technology: markers, monitoring, assessment, and control of blood glucose fluctuations in diabetes.

Kovatchev BP.

Scientifica (Cairo). 2012;2012:283821. doi: 10.6064/2012/283821. Epub 2012 Oct 17. Review.

4.

Evaluation of stochastic adjustment for glucose sensor bias during closed-loop insulin delivery.

Kollman C, Calhoun P, Lum J, Sauer W, Beck RW.

Diabetes Technol Ther. 2014 Mar;16(3):186-92. doi: 10.1089/dia.2013.0133. Epub 2013 Nov 15.

5.

Performance evaluation of three continuous glucose monitoring systems: comparison of six sensors per subject in parallel.

Freckmann G, Pleus S, Link M, Zschornack E, Klötzer HM, Haug C.

J Diabetes Sci Technol. 2013 Jul 1;7(4):842-53.

6.

Performance evaluation of a continuous glucose monitoring system under conditions similar to daily life.

Pleus S, Schmid C, Link M, Zschornack E, Klötzer HM, Haug C, Freckmann G.

J Diabetes Sci Technol. 2013 Jul 1;7(4):833-41.

7.

Performance comparison of the medtronic sof-sensor and enlite glucose sensors in inpatient studies of individuals with type 1 diabetes.

Calhoun P, Lum J, Beck RW, Kollman C.

Diabetes Technol Ther. 2013 Sep;15(9):758-61. doi: 10.1089/dia.2013.0042. Epub 2013 May 31.

8.

Use of continuous glucose monitoring as an outcome measure in clinical trials.

Beck RW, Calhoun P, Kollman C.

Diabetes Technol Ther. 2012 Oct;14(10):877-82.

9.

Real-time continuous glucose monitoring in an intensive care unit: better accuracy in patients with septic shock.

Lorencio C, Leal Y, Bonet A, Bondia J, Palerm CC, Tache A, Sirvent JM, Vehi J.

Diabetes Technol Ther. 2012 Jul;14(7):568-75. doi: 10.1089/dia.2012.0008. Epub 2012 Apr 18.

10.

Achievement of target A1C levels with negligible hypoglycemia and low glucose variability in youth with short-term type 1 diabetes and residual β-cell function.

Sherr J, Tamborlane WV, Xing D, Tsalikian E, Mauras N, Buckingham B, White NH, Arbelaez AM, Beck RW, Kollman C, Ruedy K; Diabetes Research in Children Network (DirecNet) Study Group.

Diabetes Care. 2012 Apr;35(4):817-20. doi: 10.2337/dc11-2190. Epub 2012 Feb 8.

11.

Artificial pancreas: past, present, future.

Cobelli C, Renard E, Kovatchev B.

Diabetes. 2011 Nov;60(11):2672-82. doi: 10.2337/db11-0654. Review. No abstract available.

12.

The effect of glycemic variability on counterregulatory hormone responses to hypoglycemia in young children and adolescents with type 1 diabetes.

Alghothani N, Dungan KM.

Diabetes Technol Ther. 2011 Nov;13(11):1085-9. doi: 10.1089/dia.2011.0026. Epub 2011 Jul 19.

13.

New-generation diabetes management: glucose sensor-augmented insulin pump therapy.

Cengiz E, Sherr JL, Weinzimer SA, Tamborlane WV.

Expert Rev Med Devices. 2011 Jul;8(4):449-58. doi: 10.1586/erd.11.22. Review.

14.

Can technological solutions for diabetes replace islet cell function?

Gregory JM, Moore DJ.

Organogenesis. 2011 Jan-Mar;7(1):32-41. Epub 2011 Jan 1. Review.

15.

Factors predictive of severe hypoglycemia in type 1 diabetes: analysis from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized control trial dataset.

Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Fiallo-Scharer R, Cheng J, Beck RW, Buckingham BA, Chase HP, Kollman C, Laffel L, Lawrence JM, Mauras N, Tamborlane WV, Wilson DM, Wolpert H.

Diabetes Care. 2011 Mar;34(3):586-90. doi: 10.2337/dc10-1111. Epub 2011 Jan 25.

16.

Hemoglobin A1c and mean glucose in patients with type 1 diabetes: analysis of data from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial.

Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Wilson DM, Xing D, Beck RW, Block J, Bode B, Fox LA, Hirsch I, Kollman C, Laffel L, Ruedy KJ, Steffes M, Tamborlane WV.

Diabetes Care. 2011 Mar;34(3):540-4. doi: 10.2337/dc10-1054. Epub 2011 Jan 25.

17.

Diabetes: Models, Signals, and Control.

Cobelli C, Man CD, Sparacino G, Magni L, De Nicolao G, Kovatchev BP.

IEEE Rev Biomed Eng. 2009 Jan 1;2:54-96.

18.

Validation of measures of satisfaction with and impact of continuous and conventional glucose monitoring.

Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group.

Diabetes Technol Ther. 2010 Sep;12(9):679-84.

20.

The accuracy of a new real-time continuous glucose monitoring algorithm: an analysis.

Kovatchev B, Breton M.

J Diabetes Sci Technol. 2010 Jan 1;4(1):119-22.

Supplemental Content

Support Center